Literature DB >> 18387646

Chlordecone altered hepatic disposition of [14C]cholesterol and plasma cholesterol distribution but not SR-BI or ABCG8 proteins in livers of C57BL/6 mice.

Junga Lee1, Richard C Scheri, Lawrence R Curtis.   

Abstract

Organochlorine (OC) insecticides continue to occur in tissues of humans and wildlife throughout the world although they were banned in the United States a few decades ago. Low doses of the OC insecticide chlordecone (CD) alter hepatic disposition of lipophilic xenobiotics and perturb lipid homeostasis in rainbow trout, mice and rats. CD pretreatment altered tissue and hepatic subcellular distribution of exogenous [(14)C]cholesterol (CH) equivalents 4 and 16 h after a bolus intraperitoneal (ip) injection of 5 ml corn oil/kg that contained 10 mg CH/kg. CD pretreatment altered tissue distribution of exogenously administered [(14)C]CH by decreased hepatic and renal accumulation, and increased biliary excretion up to 300%. Biliary excretion of polar [(14)C]CH metabolites was not altered by CD. CD pretreatment decreased subcellular distribution of [(14)C]CH equivalents in hepatic cytosol and microsomes and lipoprotein-rich fraction-to-homogenate ratio. CD pretreatment increased the ratio of [(14)C]CH equivalents in high density lipoprotein (HDL) to that in plasma and reduced [(14)C]CH equivalents in the non-HDL fraction 4 h after a bolus lipid dose. CD pretreatment increased plasma non-HDL total CH by 80% 4 h after a bolus lipid dose. Scavenger receptor class B type I (SR-BI) and ATP-binding cassette transporter G8 (ABCG8) proteins were quantified by western blotting in hepatic membranes from control and CD treated mice. Liver membrane contents of SR-BI and ABCG8 proteins were unchanged by CD pretreatment. The data demonstrated that a single dose of CD altered CH homeostasis and lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387646      PMCID: PMC3144140          DOI: 10.1016/j.taap.2008.01.023

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  42 in total

1.  Effects of chlorinated hydrocarbon on plasma alpha-lipoprotein cholesterol in rats.

Authors:  T Ishikawa; S McNeeley; P M Steiner; C J Glueck; M Mellies; P S Gartside; C McMillin
Journal:  Metabolism       Date:  1978-01       Impact factor: 8.694

2.  Distribution of HEOD (dieldrin) in mammals. I. Preliminary model.

Authors:  F T Lindstrom; J W Gillett; S E Rodecap
Journal:  Arch Environ Contam Toxicol       Date:  1974-03       Impact factor: 2.804

3.  Hepatobiliary dysfunction and inhibition of adenosine triphosphatase activity in bile canaliculi-enriched fractions following in vivo mirex, photomirex, and chlordecone exposures.

Authors:  L R Curtis; H M Mehendale
Journal:  Toxicol Appl Pharmacol       Date:  1981-12       Impact factor: 4.219

Review 4.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity.

Authors:  A Poland; J C Knutson
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

Review 5.  Comparative toxicology of chlordecone (Kepone) in humans and experimental animals.

Authors:  P S Guzelian
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

6.  Preferential binding of chlordecone to the protein and high density lipoprotein fractions of plasma from humans and other species.

Authors:  P J Soine; R V Blanke; P S Guzelian; C C Schwartz
Journal:  J Toxicol Environ Health       Date:  1982-01

7.  Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial.

Authors:  W J Cohn; J J Boylan; R V Blanke; M W Fariss; J R Howell; P S Guzelian
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

8.  Distribution and excretion of chlordecone (Kepone) in the rat.

Authors:  J L Egle; J B Fernandez; P S Guzelian; J F Borzelleca
Journal:  Drug Metab Dispos       Date:  1978 Jan-Feb       Impact factor: 3.922

9.  Isolation of chlordecone binding proteins from pig liver cytosol.

Authors:  P J Soine; R V Blanke; C C Schwartz
Journal:  J Toxicol Environ Health       Date:  1984

10.  High-density lipoproteins decrease the biliary concentration of chlordecone in isolated perfused pig liver.

Authors:  P J Soine; R V Blanke; V M Chinchilli; C C Schwartz
Journal:  J Toxicol Environ Health       Date:  1984
View more
  2 in total

1.  Chlordecone increased subcellular distribution of scavenger receptor class B type II to murine hepatic microsomes without altering cytosolic cholesterol binding proteins.

Authors:  Richard C Scheri; Junga Lee; Douglas F Barofsky; Lawrence R Curtis
Journal:  Toxicol Lett       Date:  2009-08-08       Impact factor: 4.372

2.  Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Yuan Zhang; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-08-26       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.